Your browser doesn't support javascript.
loading
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
Van Laethem, Jean-Luc; Riess, Hanno; Jassem, Jacek; Haas, Michael; Martens, Uwe M; Weekes, Colin; Peeters, Marc; Ross, Paul; Bridgewater, John; Melichar, Bohuslav; Cascinu, Stefano; Saramak, Piotr; Michl, Patrick; Van Brummelen, David; Zaniboni, Alberto; Schmiegel, Wollf; Dueland, Svein; Giurescu, Marius; Garosi, Vittorio L; Roth, Katrin; Schulz, Anke; Seidel, Henrik; Rajagopalan, Prabhu; Teufel, Michael; Childs, Barrett H.
Afiliación
  • Van Laethem JL; Department of Gastroenterology, Erasme University Hospital, CP 572/10, route de Lennik 808, 1070, Brussels, Belgium. JL.VanLaethem@erasme.ulb.ac.be.
  • Riess H; Medical Department, Division of Hematology, Oncology and Tumor Immunology, Charity Hospital, Virchow-Klinikum Campus, Augustenburger Platz 1, 13353, Berlin, Germany.
  • Jassem J; Department of Oncology and Radiotherapy, Medical University of Gdansk, M. Sklodowskiej-Curie 3a Street, Gdansk, 80-210, Poland.
  • Haas M; Department of Hematology and Oncology, University of Munich Medical Center, Marchioninistraße 15, 81366, Munich, Germany.
  • Martens UM; Department of Hematology and Oncology, Cancer Center Heilbronn-Franken, Am Gesundbrunnen 20-26, 74078, Heilbronn, Germany.
  • Weekes C; Division of Medical Oncology, University of Colorado Cancer Center, 1665 Aurora Ct, Aurora, CO, 80045, USA.
  • Peeters M; Department of Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium.
  • Ross P; Department of Medical Oncology, Guy's & St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
  • Bridgewater J; Department of Oncology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
  • Melichar B; Department of Oncology, Palacky University Medical School and University Hospital Olomouc, Krízkovského 8, 771 47, Olomouc, Czech Republic.
  • Cascinu S; Department of Medical Oncology, A.O.U. United Hospitals, Polytechnic University of Marche, Piazza Roma, 22, Ancona, Italy.
  • Saramak P; Department of Oncological Gastroenterology, Maria Sklodowska-Curie Memorial Cancer Center, ul. W.K. Roentgena 5, 02-781, Warsaw, Poland.
  • Michl P; Department of Gastroenterology, Endocrinology, Metabolism and Infectiology, University Hospital of Giessen and Marburg, Baldingerstraße, 35043, Marburg, Germany.
  • Van Brummelen D; Universitätsklinikum Halle - University Hospital Halle (Saale), Ernst-Grube-Straße 40, 06120, Halle (Saale), Germany.
  • Zaniboni A; Department of Radiotherapy, UZ Brussels, Avenue du Laerbeek 101, 1090, Brussels, Belgium.
  • Schmiegel W; Department of Medical Oncology, Poliambulanza Foundation Hospital Institute, Via Bissolati, 57, Brescia, Italy.
  • Dueland S; Department of Gastroenterology and Hepatology, Medical University Hospital Bochum, Alexandrinenstraße 1, Bochum, 44791, Germany.
  • Giurescu M; Department of Oncology, Oslo University Radium Hospital, Trondheimsveien 235, Bjerke, 0514, Oslo, Norway.
  • Garosi VL; Bayer Pharma AG, Müllerstraße 178, 13353, Berlin, Germany.
  • Roth K; Bayer S.p.A., Viale Certosa 126-130, 20156, Milan, Italy.
  • Schulz A; Bayer Pharma AG, Müllerstraße 178, 13353, Berlin, Germany.
  • Seidel H; Bayer Pharma AG, Müllerstraße 178, 13353, Berlin, Germany.
  • Rajagopalan P; Bayer Pharma AG, Müllerstraße 178, 13353, Berlin, Germany.
  • Teufel M; Bayer HealthCare Pharmaceuticals, Inc., 100 Bayer Blvd, Whippany, NJ, 07981, USA.
  • Childs BH; Bayer HealthCare Pharmaceuticals, Inc., 100 Bayer Blvd, Whippany, NJ, 07981, USA.
Target Oncol ; 12(1): 97-109, 2017 02.
Article en En | MEDLINE | ID: mdl-27975152

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Sulfonamidas / Desoxicitidina / Difenilamina / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Sulfonamidas / Desoxicitidina / Difenilamina / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Bélgica